Neurofilament light chain level is a weak risk factor for the development of MS. - Wikidata - awgldk - TriplyDB

Neurofilament light chain level is a weak risk factor for the development of MS.

Neurofilament light chain level is a weak risk factor for the development of MS.

http://www.wikidata.org/entity/Q37265143

about

An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.Neurofilaments in CSF As Diagnostic Biomarkers in Motor Neuron Disease: A Meta-Analysis.Biomarkers in the evolution of multiple sclerosis.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.Association between NEFL Gene Polymorphisms and Neuroblastoma Risk in Chinese Children: A Two-Center Case-Control Study.Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study

P2860

Q39027028-62205BC7-FF3F-472A-A29D-6F291C72333E Q39103639-276FF928-2AFD-421C-9254-F0338F5BFF22 Q47578484-85706CBE-0DF8-497A-A705-85BC079109AC Q47638443-F9A73072-D3F7-40F6-9513-099FF950E8D1 Q51110507-CED542BE-8CB5-4930-9871-F598424AC092 Q52093939-5315C26F-3609-46DE-941C-232B644E64B1 Q52684207-06D87C73-9A20-462B-AE5D-4EE2C2FD9B7D Q57161829-1F5DDF75-4F1E-4017-9D55-E152994E4801

P2860

Neurofilament light chain level is a weak risk factor for the development of MS.

http://www.wikidata.org/entity/Q37265143

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neurofilament light chain level is a weak risk factor for the development of MS.

@en

Neurofilament light chain level is a weak risk factor for the development of MS.

@nl

type

label

Neurofilament light chain level is a weak risk factor for the development of MS.

@en

Neurofilament light chain level is a weak risk factor for the development of MS.

@nl

prefLabel

Neurofilament light chain level is a weak risk factor for the development of MS.

@en

Neurofilament light chain level is a weak risk factor for the development of MS.

@nl

P1433

Q37265143-BBE97074-B234-4DF3-A115-A130016518B0

P1476

Q37265143-25CA0EFD-C0FF-4978-8C3E-49762177E83C

P2093

Q37265143-08953BE1-4ED3-4E87-9EAF-0710268C8283

Q37265143-17E8FC1D-AA58-4D32-ABE3-E1DC2B65E045

Q37265143-1E74EDAD-9881-4A81-947C-9C3F7DBD39BF

Q37265143-249BB15C-F4B7-407B-B0F9-4C4B30EE9414

Q37265143-3A2E6271-5A1B-4A1A-8787-0676997D786E

Q37265143-48AC53A0-92DE-4109-A9C2-00466A83687A

Q37265143-49363889-FEF6-4654-8444-2B0E3EBF7284

Q37265143-85AD50F4-2B84-451F-9CB0-40B67408EA8F

Q37265143-9EFDA7CC-5698-46C2-9AE7-D020AE2C08C0

Q37265143-A92BABCC-DD49-48C7-B8DD-B37F42021F6E

P2860

Q37265143-05F5385B-444C-4419-89B7-22938F9434F8

Q37265143-1BA8A7ED-65F6-4BE1-BF87-6F4AD44F5B36

Q37265143-2A293442-3FEE-41D4-99A2-ADE35C7E9B4C

Q37265143-302F3FF8-DEA2-4EFC-AA73-BCDA61506FED

Q37265143-34F9C8E0-E6FA-4066-AA1F-EBA472969454

Q37265143-3A3CC68F-FF8A-4CA5-9A9E-75F41F1F5D69

Q37265143-3A49BE5F-A459-4B6E-AD89-2000464F0604

Q37265143-41180501-0B8F-4964-B05D-C60CF96AE04E

Q37265143-47CB2F81-FED9-4F0B-A7EB-68A5CB7710EF

Q37265143-4B966A31-48F9-4765-9CD1-CB42CA1C38C5

P304

Q37265143-ECB3B762-7C51-4EB6-8D60-5E11DF23239C

P31

Q37265143-BC09E893-E1A6-4489-B80D-FCFCAF0E6BBC

P356

Q37265143-2CC9D5D3-2889-43A7-8A6C-149C137EFECF

P407

Q37265143-7FA3ED76-7126-44EF-8172-42364E20DBC8

P433

Q37265143-9A7BD920-33B1-400A-8C1A-F45E60D78F54

P478

Q37265143-32AE1A8E-FA61-410B-9F25-19E8904CAF74

P50

Q37265143-0F11E53E-FC77-4A31-A2B1-E7BFE7673061

Q37265143-13527239-F192-4A43-A885-C748C7B65B64

Q37265143-15C6CF47-BA80-422F-A3C9-C38EDB03642F

Q37265143-5DD5AB3A-F043-4FC4-88FB-5FF7F7D079EF

Q37265143-70F47B91-7736-4F0F-84C5-CE014A308F4E

Q37265143-75368F1D-EF98-430E-9BD5-B8A67B7285A5

Q37265143-7606E324-3BFD-430B-876C-6B689AD1BCA4

Q37265143-84512C51-8A49-482C-8E06-3CF44D71A1EB

Q37265143-86D19280-4158-4F9B-AD98-400C86F64362

Q37265143-8F24A07B-C0C2-4D2D-B878-4B78795AF305

P577

Q37265143-B7579E62-CF59-4AA1-9035-82D778F5DD07

P698

Q37265143-C302F7AD-D735-4CF1-9D84-5217CC96E86B

P921

Q37265143-8E0B6D8D-EA49-40BA-BAD1-8FB24CB78273

P932

Q37265143-90EDFFAE-4F5C-4EC6-BF35-559F6A71394E

P356

WNL.0000000000003085

P1433

P1476

Neurofilament light chain level is a weak risk factor for the development of MS

@en

P2093

Alex Rovira

http://www.w3.org/2001/XMLSchema#string

Carlos Nos

http://www.w3.org/2001/XMLSchema#string

Carmen Picón

http://www.w3.org/2001/XMLSchema#string

Cristina Auger

http://www.w3.org/2001/XMLSchema#string

Eva Simon

http://www.w3.org/2001/XMLSchema#string

Giulio Disanto

http://www.w3.org/2001/XMLSchema#string

Jens Kuhle

http://www.w3.org/2001/XMLSchema#string

Joaquín Castilló

http://www.w3.org/2001/XMLSchema#string

José C Alvarez-Cermeño

http://www.w3.org/2001/XMLSchema#string

Ludwig Kappos

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Body fluid biomarkers in multiple sclerosis

Advances in functional and structural MR image analysis and implementation as FSL

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.

Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss.

Neurofascin as a novel target for autoantibody-mediated axonal injury

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.

P304

1076-1084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000003085

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Angela Vidal-Jordana

Jaume Sastre Garriga

Xavier Montalban

P577

2016-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27521440

http://www.w3.org/2001/XMLSchema#string

P921

P932

5027802

http://www.w3.org/2001/XMLSchema#string